UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:September 30,
Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Tenax Therapeutics Charts.
Tenax Therapeutics (NASDAQ:TENX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Tenax Therapeutics Charts.

Tenax Therapeutics, Inc. News

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Tuesday 30 April 2024 (3 days ago) • GlobeNewswire Inc.
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
Tuesday 9 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
Thursday 28 March 2024 (1 month ago) • GlobeNewswire Inc.
Tenax Therapeutics to Present at the 36th Annual Roth Conference
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.
Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
Wednesday 21 February 2024 (2 months ago) • GlobeNewswire Inc.
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)

More Tenax Therapeutics, Inc. News Articles